Uroplasty expands incontinence line with CystoMedix buy
This article was originally published in Clinica
Executive Summary
Minneapolis firm Uroplasty has expanded its range of incontinence products with the acquisition of fellow US company CystoMedix, of Andover. Terms of the deal have yet to be decided, but Uroplasty says it expects to pay a mixture of cash and stock, and complete by the end of March 2005.